BIOPHEN LMWH Control C4, REF 224201
FDA Device Recall #Z-1190-2019 — Class III — March 19, 2019
Recall Summary
| Recall Number | Z-1190-2019 |
| Classification | Class III — Low risk |
| Date Initiated | March 19, 2019 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Aniara Diagnostica LLC |
| Location | West Chester, OH |
| Product Type | Devices |
| Quantity | 3 units |
Product Description
BIOPHEN LMWH Control C4, REF 224201
Reason for Recall
The manufacturer packaged incorrect versions of the Instructions for Use into specific lots for three device product codes.
Distribution Pattern
Distributed to accounts in MI and PA.
Lot / Code Information
Lots F1701555P4
Other Recalls from Aniara Diagnostica LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1227-2023 | Class II | BIOPHEN Protein C 5 kit is for in vitro quantit... | Feb 1, 2023 |
| Z-1743-2022 | Class III | BIOPHEN UFH Control Plasma | Jun 28, 2022 |
| Z-2346-2019 | Class II | ZYMUTEST HIA MonoStrip, IgG ELISA kit, Model No... | Jul 19, 2019 |
| Z-2347-2019 | Class II | ZYMUTEST HIA MonoStrip, IgGAM ELISA kit, Model ... | Jul 19, 2019 |
| Z-1189-2019 | Class III | BIOPHEN UFH Control C1, REF 224101 | Mar 19, 2019 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.